Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.

Scientists from the Institute of Molecular Genetics of the Czech Academy of Sciences, in collaboration with the Faculty of ...

A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...

The immune system provides constant surveillance for the body, aiming to spot and eliminate disease-causing microbes or ...

It's true that vitamin C can give your immune system a boost, but when it comes to treating or preventing colds, things get a ...

New research links inflammation to mental health symptoms. Personalized care using brain and immune data could improve ...

First identified in Japan in 2009, the fungus has reportedly reached at least 60 countries and dozens of US states.

Long before memory problems appear, your brain may already be losing neurons. That is the unsettling message from new work by ...

Immune cells work to fight infection and other diseases. Different subsets work together to elicit a healthy immune response; ...

Researchers at MIT have unveiled a way to coax an aging immune system into acting young again, using the same kind of mRNA ...

Researchers at Texas Biologics at The University of Texas at Austin recently made a discovery that they believe could ...

Explore this year’s highlights in immunology research.